Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Drug Dissolution: Requirements and Profile Comparison
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 13, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
Published on: March 17, 2023
Jufang Wu Ludvigsson1, Anders Karlsson1, Viktor Kjellberg1
1Pharmaceutical Technology and Development, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Core-shell particles offer comparable performance to sub-2 µm fully porous particles in fast liquid chromatography, with significantly lower back pressure. This study characterized various core-shell C18 columns to assess their suitability for pharmaceutical analysis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: